Build vs Buy for Healthcare Software: How to Decide

The buyer’s problem is not really build vs. buy

Most healthcare teams do not fail because they picked the wrong vendor in a vacuum. They fail because they treated build vs. buy as a software preference instead of a business and operating model decision. A Series A digital health founder has to think about runway, integration risk, compliance, and whether the product will still matter after the first implementation. A CTO at a healthcare IT vendor has to think about release velocity, maintainability, and whether the team can support the architecture after the deal closes. A provider innovation lead has to think about change management, security review, and whether the solution can survive contact with frontline workflows.

The wrong choice usually shows up in one of three places: the team spends too long stitching together point solutions, the vendor cannot fit the real workflow, or the custom build becomes an unmaintainable tax. We have seen all three. In one case, a team bought a platform that looked faster on paper, only to discover that every workflow exception required manual workarounds. In another, a team overbuilt internal tooling for a narrow use case and then spent two years maintaining something that should have been a service contract.

AST’s build vs. buy framework

We do not start with technology. We start with the business outcome and the operational constraints. If the product must integrate with Epic, Cerner, or PointClickCare, or if it has to sit inside a HIPAA-controlled environment, the architecture has to be chosen with deployment, auditability, and supportability in mind. That changes the answer fast.

Here is the practical comparison we use with healthcare teams.

Four technical approaches that actually work

1) Buy the commodity layer, build the workflow layer

This is the strongest pattern for digital health products with real differentiation. Use commercial tools for things like identity, billing primitives, messaging, or commodity analytics. Build the patient journey, clinician workflow, care coordination logic, or revenue cycle decisioning where your product actually creates value. Architecturally, this means clean service boundaries, explicit event contracts, and a narrow set of integration points so you can swap vendors without rewriting the product.

2) Build the domain core in-house

If your defensibility depends on a unique clinical or operational process, own the core logic. This matters for ambient documentation, utilization management, care navigation, and revenue cycle automation. The hard part is not writing code; it is designing the data model, exception handling, and observability so the system behaves predictably under real operational load. Teams that take this path need strong engineering discipline, QA, and release management from day one.

3) Keep infrastructure managed, own product control

Many healthcare teams should not be building raw cloud plumbing. Use managed services for storage, queues, identity, and audit logging, then focus the team on business logic and integrations. If you are operating in HIPAA-regulated environments, this reduces attack surface and speeds up security review. The key is to avoid lock-in at the workflow layer while still using managed services where they save time and reduce operational burden.

4) Use an embedded engineering pod

This is where AST fits best. If you need a team that can own delivery end-to-end without turning into a staff aug arrangement, our pod model gives you developers, QA, DevOps, and product-minded execution in one unit. We have built clinical software for a 160+ facility respiratory care network, and the pattern is consistent: healthcare products fail when QA, infrastructure, and workflow design are isolated from the product team. They succeed when the team owns the release from ticket to production monitoring.

When build wins, and when it does not

Build wins when the software is part of your product moat, when workflows are messy enough that vendors force compromise, or when regulatory and reporting obligations make black-box behavior unacceptable. Build also wins when integration is the product. If your success depends on coordinating data across EHRs, internal systems, and patient-facing tools, the orchestration itself becomes strategic.

Buy wins when the function is standard and the switching cost is low. Do not build custom scheduling, generic CRM behavior, or baseline identity workflows unless they directly change your economics. We see teams overbuild because they assume custom code equals control. It does not. Control comes from good boundaries, clear ownership, testing, and the ability to ship safely.

AST’s decision framework for healthcare software teams

1. Separate commodity from differentiator Identify which parts of the workflow are table stakes and which parts drive retention, margin, or care quality.
2. Map compliance and integration burden Score each option against HIPAA, security review, implementation time, and external dependencies such as Epic, Cerner, or PointClickCare.
3. Stress test ownership Ask who will support releases, handle incidents, manage upgrades, and maintain the code or vendor relationship 18 months from now.
4. Evaluate operating speed If the team cannot ship and validate safely, buying may be smarter for now. If the product must move fast and stay differentiated, build the core.
5. Decide the team model If you need execution capacity without losing control, an embedded pod can be the best middle ground.

We use this exact logic when advising founders and product leaders. The answer is rarely “build everything” or “buy everything.” It is usually a careful split between what should be standardized and what should remain under your control.

What AST has learned from real healthcare builds

When our team built clinical software supporting 160+ respiratory care facilities, the biggest lesson was that workflow exceptions are not edge cases in healthcare. They are the product. If the system cannot handle missed data, delayed documentation, or a provider-specific variation without breaking, it is not ready.

We have also seen that implementation quality matters as much as feature quality. A team can buy a strong platform and still fail if the integration surface is brittle or the rollout plan ignores frontline reality. That is why AST embeds delivery teams that think about product behavior, not just code completion. We do not treat QA as a final checkpoint. We treat it as part of product design.

For teams building ambient clinical documentation, revenue cycle tooling, or EMR-adjacent products, that discipline matters. The system needs to survive real-world load, partial data, workflow variance, and security review. If it cannot, the business will feel it immediately.